Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 3
1949 2
1950 3
1951 2
1952 3
1953 1
1954 5
1955 4
1956 7
1957 5
1958 4
1959 8
1960 7
1961 1
1962 1
1963 2
1964 6
1965 1
1966 3
1967 7
1968 5
1969 1
1970 4
1971 1
1972 4
1975 2
1976 2
1977 2
1978 2
1979 6
1980 6
1981 3
1982 4
1983 5
1984 7
1985 4
1986 5
1987 5
1988 3
1989 3
1990 7
1991 7
1992 1
1993 3
1994 5
1995 2
2001 1
2003 1
2006 1
2008 2
2009 3
2010 1
2011 2
2012 2
2013 1
2014 1
2015 1
2016 1
2018 2
2019 1
2020 1
2021 1
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.
Triplett TA, Garrison KC, Marshall N, Donkor M, Blazeck J, Lamb C, Qerqez A, Dekker JD, Tanno Y, Lu WC, Karamitros CS, Ford K, Tan B, Zhang XM, McGovern K, Coma S, Kumada Y, Yamany MS, Sentandreu E, Fromm G, Tiziani S, Schreiber TH, Manfredi M, Ehrlich LIR, Stone E, Georgiou G. Triplett TA, et al. Among authors: fromm g. Nat Biotechnol. 2018 Sep;36(8):758-764. doi: 10.1038/nbt.4180. Epub 2018 Jul 16. Nat Biotechnol. 2018. PMID: 30010674 Free PMC article.
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.
Memon D, Schoenfeld AJ, Ye D, Fromm G, Rizvi H, Zhang X, Keddar MR, Mathew D, Yoo KJ, Qiu J, Lihm J, Miriyala J, Sauter JL, Luo J, Chow A, Bhanot UK, McCarthy C, Vanderbilt CM, Liu C, Abu-Akeel M, Plodkowski AJ, McGranahan N, Łuksza M, Greenbaum BD, Merghoub T, Achour I, Barrett JC, Stewart R, Beltrao P, Schreiber TH, Minn AJ, Miller ML, Hellmann MD. Memon D, et al. Among authors: fromm g. Cancer Cell. 2024 Feb 12;42(2):209-224.e9. doi: 10.1016/j.ccell.2023.12.013. Epub 2024 Jan 11. Cancer Cell. 2024. PMID: 38215748 Free article.
Shining a LIGHT on myeloid cell targeted immunotherapy.
Shuptrine CW, Perez VM, Selitsky SR, Schreiber TH, Fromm G. Shuptrine CW, et al. Among authors: fromm g. Eur J Cancer. 2023 Jul;187:147-160. doi: 10.1016/j.ejca.2023.03.040. Epub 2023 Apr 5. Eur J Cancer. 2023. PMID: 37167762 Free article. Review.
Pre-trigeminal neuralgia.
Fromm GH, Graff-Radford SB, Terrence CF, Sweet WH. Fromm GH, et al. Neurology. 1990 Oct;40(10):1493-5. doi: 10.1212/wnl.40.10.1493. Neurology. 1990. PMID: 2215936
Gabapentin: discussion.
Fromm GH. Fromm GH. Epilepsia. 1994;35 Suppl 5:S77-80. doi: 10.1111/j.1528-1157.1994.tb05975.x. Epilepsia. 1994. PMID: 8039476 Review.
LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.
Yoo KJ, Johannes K, González LE, Patel A, Shuptrine CW, Opheim Z, Lenz K, Campbell K, Nguyen TA, Miriyala J, Smith C, McGuire A, Tsai YH, Rangwala F, de Silva S, Schreiber TH, Fromm G. Yoo KJ, et al. Among authors: fromm g. J Immunol. 2022 Aug 1;209(3):510-525. doi: 10.4049/jimmunol.2101175. Epub 2022 Jul 11. J Immunol. 2022. PMID: 35817517 Free PMC article.
Baclofen as an adjuvant analgesic.
Fromm GH. Fromm GH. J Pain Symptom Manage. 1994 Nov;9(8):500-9. doi: 10.1016/0885-3924(94)90111-2. J Pain Symptom Manage. 1994. PMID: 7852758 Free article. Review.
SnapShot: Transcription regulation: pausing.
Fromm G, Gilchrist DA, Adelman K. Fromm G, et al. Cell. 2013 May 9;153(4):930-930.e1. doi: 10.1016/j.cell.2013.04.011. Cell. 2013. PMID: 23663787 Free article. No abstract available.
Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses.
Shuptrine CW, Chen Y, Miriyala J, Lenz K, Moffett D, Nguyen TA, Michaux J, Campbell K, Smith C, Morra M, Rivera-Molina Y, Murr N, Cooper S, McGuire A, Makani V, Oien N, Zugates JT, de Silva S, Schreiber TH, de Picciotto S, Fromm G. Shuptrine CW, et al. Among authors: fromm g. Cancer Res. 2024 May 15;84(10):1550-1559. doi: 10.1158/0008-5472.CAN-23-2875. Cancer Res. 2024. PMID: 38381555 Free PMC article.
201 results